Drug Trial Radar · NCT03037931
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-Study
Last checked: Nov 20, 2026Latest source record: Jul 3, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
3,065
Actual
Start
Mar 15, 2017
Primary completion
Feb 2, 2023
Study completion Feb 2, 2023
Sponsor
- Lead sponsor
- American Regent, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Duke Clinical Research Institute
- First posted
- Jan 31, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to determine the efficacy and safety of iron therapy using intravenous (IV) ferric carboxymaltose (FCM), relative to placebo in the treatment of participants in heart failure with a reduced ejection fraction and with iron deficiency
Conditions
- Heart Failure
- Iron-deficiency
Interventions
Ferric CarboxymaltoseDrug
Intravenous Iron
PlaceboDrug
Normal Saline Solution
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of DeathsTime frame: 1 year
- Number of Hospitalizations for Heart FailureTime frame: 1 year
- Change in 6MWT (Six Minute Walk Test) DistanceTime frame: 6 months
Locations
345 sites in 13 countries. Site status is shown where the registry gives one.
Advanced Cardiovascular LLC
Alexander City, Alabama
Advanced Cardiovascular, LLC
Auburn, Alabama
IMC/Diagnostic & Medical Clinic
Mobile, Alabama
University of South Alabama
Mobile, Alabama
Alaska Heart & Vascular Institute
Anchorage, Alaska
Verde Valley Medical Center
Cottonwood, Arizona
Clinical Research Institute of Arizona, LLC
Surprise, Arizona
Carondelet Heart and Vascular Institute - Cardiology East
Tucson, Arizona
Sparks Regional Medical Center
Fort Smith, Arkansas
NEA Baptist Clinic
Jonesboro, Arkansas
Arkansas Heart Hospital
Little Rock, Arkansas
Westside Medical Associates of Los Angeles
Beverly Hills, California
Harbor-UCLA Medical Center
Carson, California
Valley Clinical Trials, Inc.
Covina, California
TriWest Research Associates, LLC
El Cajon, California
California Heart Specialists
Huntington Beach, California
First Valley Medical Group
Lancaster, California
Healthcare Partners Affiliation Medical Group
Long Beach, California
Axis Clinical Trials
Los Angeles, California
St. Joseph Heritage-Healthcare
Mission Viejo, California
Radin Cardiovascular Medical Group, Inc.
Newport Beach, California
Valley Clinical Trials, Inc.
Northridge, California
Pasadena Clinical Research
Pasadena, California
Eugene Soroka, MD Inc.
Port Hueneme, California
VA San Diego Health Care System
San Diego, California
Interventional Cardiology Medical Group
West Hills, California
South Denver Cardiology Associates, PC
Littleton, Colorado
Danbury Hospital
Danbury, Connecticut
Stamford Hospital
Stamford, Connecticut
Christiana Care
Newark, Delaware
Alfieri Cardiology
Wilmington, Delaware
Cardiology Associates of South Florida
Boynton Beach, Florida
Cardiovascular & Vein Center of Florida
Bradenton, Florida
Innovative Research of West Florida, Inc.
Clearwater, Florida
Avail Clinical Research, LLC
DeLand, Florida
Riverside Clinical Research
Edgewater, Florida
Memorial Regional Hospital
Hollywood, Florida
St. Vincent's Healthcare - Riverside
Jacksonville, Florida
UF Health Jacksonville
Jacksonville, Florida
St. Vincent's Healthcare - Southside Recruiting
Jacksonville, Florida
Showing 40 of 345 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.